As Vice President at Ora, Inc., Debby Brown plays a pivotal role in advancing the field of clinical trials through her expertise in Risk-Based Monitoring (RBM) strategies. With a rich background in clinical operations and development, Debby has been instrumental in shaping the future of...
As Vice President at Ora, Inc., Debby Brown plays a pivotal role in advancing the field of clinical trials through her expertise in Risk-Based Monitoring (RBM) strategies. With a rich background in clinical operations and development, Debby has been instrumental in shaping the future of quality-based trials since her early involvement with the Clinical Trials Transformation Initiative (CTTI). Her current focus is on developing and deploying innovative strategies that enhance RBM activities, ensuring that clinical trials are not only efficient but also maintain the highest standards of quality and compliance.
Debby’s extensive skill set encompasses remote monitoring, analytical skills, and regulatory submissions, all of which are critical in navigating the complexities of drug development. She leads key projects aimed at integrating electronic data capture (EDC) systems with RBM methodologies, thereby streamlining data collection and analysis processes. Her leadership in CRO management has also fostered strong partnerships that enhance operational efficiencies and drive successful trial outcomes.
Under her guidance, Ora, Inc. is at the forefront of implementing best practices in clinical monitoring, leveraging technology to improve patient safety and data integrity. Debby’s vision for the future of clinical trials is one where risk is effectively managed, allowing for more adaptive and responsive trial designs. As she continues to champion the development of RBM skills within her team, Debby is not only fulfilling a personal ambition but is also contributing significantly to the evolution of clinical trial methodologies, ultimately benefiting patients and the broader healthcare landscape.
